市場調查報告書
商品編碼
1030451

全球妥瑞症治療市場:各產品(抗精神病藥,非抗精神病藥),各地區預測(2021年∼2027年)

Global Tourette syndrome Treatment Market is segmented by Product (Antipsychotics and Non-Antipsychotics), Regional Forecasts 2021-2027

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球妥瑞症治療市場規模在2021年∼2027年間預測將以10.41%的年複合成長率增長。

對妥瑞症研究的日益關注和妥瑞症病例增加推動了該市場的成長。

本報告提供全球妥瑞症治療市場的相關調查,提供市場動態,產業分析,市場分析,競爭資訊等全面性資訊。

目錄

第1章 摘要整理

第2章 全球妥瑞症治療市場定義和範圍

第3章 全球妥瑞症治療市場動態

  • 妥瑞症治療市場影響分析(2019年∼2027年)

第4章 全球妥瑞症治療市場產業分析

  • 波特的五力分析模式
  • PEST分析
  • 投資採用模式
  • 分析師的推薦事項與結論

第5章 全球妥瑞症治療市場:各產品

  • 市場概述
  • 全球妥瑞症治療市場各產品的效能-潛在分析
  • 2018年∼2027年的全球妥瑞症治療市場各產品推算及預測(10億美元)
  • 妥瑞症治療市場子區隔分析
    • 抗精神病藥
    • 非抗精神病藥

第6章 全球妥瑞症治療市場地區分析

  • 地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲概述
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區概述
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他
  • 南美概述
    • 巴西
    • 墨西哥
  • 其他

第7章 競爭資訊

  • 主要企業的市場策略
  • 企業簡介
    • Otsuka Holdings Co. Ltd.
    • AstraZeneca Plc
    • Boehringer Ingelheim International GmbH
    • Auspex Pharmaceuticals, Inc.
    • Reviva Pharmaceuticals Inc.
    • Mylan NV
    • Catalyst Pharmaceutical
    • Pfizer Inc.
    • Teva Pharmaceuticals
    • Zydus Pharmaceuticals

第8章 調查流程

目錄

Global Tourette syndrome Treatment Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 10.41% over the forecast period 2021-2027. Tourette syndrome is a neuropsychiatric disorder that manifests itself via physical and vocal tics. Tics are non-rhythmic, repetitive movements of a single muscle group that are caused by a genetic mutation that prevents the brain from producing histamine. The primary cause of Tourette syndrome is a disruption in the balance of neurotransmitters in the brain, which transmit nerve signals from cell to cell. This condition is related to the use of obscene words or making socially inappropriate statements. Tourette syndrome is a child and adolescent hereditary disease. The market is driven by rising focus on Tourette Syndrome research and increasing cases of Tourette Syndrome. According to CDC research, one in every 360 (0.3 percent) children aged 6 to 17 in the United States has been diagnosed with TS, totaling about 138,000 children. In addition, 37% of children diagnosed with TS have been reported to have moderate or severe diseases or conditions. The CDC is also cooperating with the Tourette Association of America to expand access to CBIT (Comprehensive Behavioral Intervention for Tics), provide education and outreach, improve acceptance and reduce stigma through the Tourette Association Youth Ambassador Program, and provide resources to help individuals and families living with Tourette, such as school resources.

However, lack of awareness in developing region may impede market growth over the forecast period of 2021-2027.

North America dominates the global Tourette syndrome market due to the presence of a larger number of important players such as Catalyst Pharmaceutical Partners, Inc., AstraZeneca PLC, and Otsuka Holdings Co., Ltd in the region. Europe is the second-largest market for Tourette syndrome. Because of its high incidence rate, the Tourette syndrome market has grown across Europe. Furthermore, the Tourette syndrome market in Asia Pacific is growing as patients become more aware of the status.

Major market player included in this report are:

Otsuka Holdings Co. Ltd.

AstraZeneca Plc

Boehringer Ingelheim International GmbH

Auspex Pharmaceuticals, Inc.

Reviva Pharmaceuticals Inc.

Mylan NV

Catalyst Pharmaceutical

Pfizer Inc.

Teva Pharmaceuticals

Zydus Pharmaceuticals

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Antipsychotics

Non Antipsychotics

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027.

Target Audience of the Global Tourette syndrome Treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Tourette Syndrome Treatment Market, by Region, 2019-2027 (USD Billion)
    • 1.2.2. Tourette Syndrome Treatment Market, by Product, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Tourette Syndrome Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Tourette Syndrome Treatment Market Dynamics

  • 3.1. Tourette Syndrome Treatment Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising focus on Tourette Syndrome research
      • 3.1.1.2. Increasing cases of Tourette Syndrome
    • 3.1.2. Market Restraint
      • 3.1.2.1. Lack of awareness in developing region
      • 3.1.2.2. Withdrawal of the drugs in late stages of clinical trials
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increase in research and development

Chapter 4. Global Tourette Syndrome Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Tourette Syndrome Treatment Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Tourette Syndrome Treatment Market by Product, Performance - Potential Analysis
  • 5.3. Global Tourette Syndrome Treatment Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
  • 5.4. Tourette Syndrome Treatment Market , Sub Segment Analysis
    • 5.4.1. Antipsychotics
    • 5.4.2. Non Antipsychotics

Chapter 6. Global Tourette Syndrome Treatment Market, Regional Analysis

  • 6.1. Tourette Syndrome Treatment Market , Regional Market Snapshot
  • 6.2. North America Tourette Syndrome Treatment Market
    • 6.2.1. U.S. Tourette Syndrome Treatment Market
      • 6.2.1.1. Product breakdown estimates & forecasts, 2018-2027
    • 6.2.2. Canada Tourette Syndrome Treatment Market
  • 6.3. Europe Tourette Syndrome Treatment Market Snapshot
    • 6.3.1. U.K. Tourette Syndrome Treatment Market
    • 6.3.2. Germany Tourette Syndrome Treatment Market
    • 6.3.3. France Tourette Syndrome Treatment Market
    • 6.3.4. Spain Tourette Syndrome Treatment Market
    • 6.3.5. Italy Tourette Syndrome Treatment Market
    • 6.3.6. Rest of Europe Tourette Syndrome Treatment Market
  • 6.4. Asia-Pacific Tourette Syndrome Treatment Market Snapshot
    • 6.4.1. China Tourette Syndrome Treatment Market
    • 6.4.2. India Tourette Syndrome Treatment Market
    • 6.4.3. Japan Tourette Syndrome Treatment Market
    • 6.4.4. Australia Tourette Syndrome Treatment Market
    • 6.4.5. South Korea Tourette Syndrome Treatment Market
    • 6.4.6. Rest of Asia Pacific Tourette Syndrome Treatment Market
  • 6.5. Latin America Tourette Syndrome Treatment Market Snapshot
    • 6.5.1. Brazil Tourette Syndrome Treatment Market
    • 6.5.2. Mexico Tourette Syndrome Treatment Market
  • 6.6. Rest of The World Tourette Syndrome Treatment Market

Chapter 7. Competitive Intelligence

  • 7.1. Top Market Strategies
  • 7.2. Company Profiles
    • 7.2.1. Otsuka Holdings Co. Ltd.
      • 7.2.1.1. Key Information
      • 7.2.1.2. Overview
      • 7.2.1.3. Financial (Subject to Data Availability)
      • 7.2.1.4. Product Summary
      • 7.2.1.5. Recent Developments
    • 7.2.2. AstraZeneca Plc
    • 7.2.3. Boehringer Ingelheim International GmbH
    • 7.2.4. Auspex Pharmaceuticals, Inc.
    • 7.2.5. Reviva Pharmaceuticals Inc.
    • 7.2.6. Mylan NV
    • 7.2.7. Catalyst Pharmaceutical
    • 7.2.8. Pfizer Inc.
    • 7.2.9. Teva Pharmaceuticals
    • 7.2.10. Zydus Pharmaceuticals

Chapter 8. Research Process

  • 8.1. Research Process
    • 8.1.1. Data Mining
    • 8.1.2. Analysis
    • 8.1.3. Market Estimation
    • 8.1.4. Validation
    • 8.1.5. Publishing
  • 8.2. Research Attributes
  • 8.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Tourette Syndrome Treatment Market, report scope
  • TABLE 2. Global Tourette Syndrome Treatment Market estimates & forecasts by region 2018-2027 (USD Billion)
  • TABLE 3. Global Tourette Syndrome Treatment Market estimates & forecasts by Product 2018-2027 (USD Billion)
  • TABLE 4. Global Tourette Syndrome Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 5. Global Tourette Syndrome Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 6. Global Tourette Syndrome Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 7. Global Tourette Syndrome Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 8. Global Tourette Syndrome Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Tourette Syndrome Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Tourette Syndrome Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Tourette Syndrome Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Tourette Syndrome Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Tourette Syndrome Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Tourette Syndrome Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global Tourette Syndrome Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. Global Tourette Syndrome Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. Global Tourette Syndrome Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 18. Global Tourette Syndrome Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 19. Global Tourette Syndrome Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 20. U.S. Tourette Syndrome Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 21. U.S. Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 22. U.S. Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 23. Canada Tourette Syndrome Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 24. Canada Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 25. Canada Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 26. UK Tourette Syndrome Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 27. UK Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 28. UK Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 29. Germany Tourette Syndrome Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 30. Germany Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 31. Germany Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 32. France Tourette Syndrome Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 33. France Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 34. France Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 35. Spain Tourette Syndrome Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 36. Spain Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 37. Spain Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 38. Italy Tourette Syndrome Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 39. Italy Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 40. Italy Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 41. ROE Tourette Syndrome Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 42. ROE Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 43. ROE Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 44. China Tourette Syndrome Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 45. China Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 46. China Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 47. India Tourette Syndrome Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 48. India Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 49. India Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 50. Japan Tourette Syndrome Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 51. Japan Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 52. Japan Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 53. Australia Tourette Syndrome Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 54. Australia Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 55. Australia Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 56. South Korea Tourette Syndrome Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 57. South Korea Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 58. South KoreaTourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 59. ROPAC Tourette Syndrome Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 60. ROPAC Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 61. ROPAC Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 62. Brazil Tourette Syndrome Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 63. Brazil Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 64. Brazil Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 65. Mexico Tourette Syndrome Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 66. Mexico Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 67. Mexico Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 68. ROLA Tourette Syndrome Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 69. ROLA Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 70. ROLA Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 71. ROW Tourette Syndrome Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 72. ROW Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 73. ROW Tourette Syndrome Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 74. List of secondary sources used in the study of Global Tourette Syndrome Treatment Market.
  • TABLE 75. List of primary sources used in the study of Global Tourette Syndrome Treatment Market.
  • TABLE 76. Years considered for the study.
  • TABLE 77. Exchange rates considered.

LIST OF FIGURES

List of figures

  • FIG 1. Global Tourette Syndrome Treatment Market, research methodology
  • FIG 2. Global Tourette Syndrome Treatment Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Tourette Syndrome Treatment Market, key trends 2020
  • FIG 5. Global Tourette Syndrome Treatment Market, growth prospects 2021-2027
  • FIG 6. Global Tourette Syndrome Treatment Market, porters 5 force model
  • FIG 7. Global Tourette Syndrome Treatment Market, pest analysis
  • FIG 8. Global Tourette Syndrome Treatment Market, value chain analysis
  • FIG 9. Global Tourette Syndrome Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Tourette Syndrome Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Tourette Syndrome Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Tourette Syndrome Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Tourette Syndrome Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Tourette Syndrome Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 15. Global Tourette Syndrome Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 16. Global Tourette Syndrome Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 17. Global Tourette Syndrome Treatment Market, regional snapshot 2018 & 2027
  • FIG 18. North America Tourette Syndrome Treatment Market 2018 & 2027 (USD Billion)
  • FIG 19. Europe Tourette Syndrome Treatment Market 2018 & 2027 (USD Billion)
  • FIG 20. Asia-Pacific Tourette Syndrome Treatment Market 2018 & 2027 (USD Billion)
  • FIG 21. Latin America Tourette Syndrome Treatment Market 2018 & 2027 (USD Billion)
  • FIG 22. Global Tourette Syndrome Treatment Market, company market share analysis (2020)